ERBB2 and cancer: In this work, we proposed a bispecific targeting strategy and assessed this strategy by developing and testing a pair of BsAbs designed to induce co-phagocytosis of VEGFA (an example of a soluble target in the TME) via inducing ADCP of cancer cells overexpressing HER2 (an example of a solid target overexpressed on cancer cells).